Which one of the following therapies would be safe in a patient with pulmonary tuberculosis having markedly abnormal liver function -: (A) Streptomycin + isoniazid, (B) Ethambutol + isoniazid, (C) Rifampicin + isoniazid, (D) Streptomycin + ethambutol
Answer is D. None